Rheumatoid Arthritis: Why the Immune System Attacks the Joints — and What Actually Helps

If you've noticed your knuckles stiff and swollen in the mornings — worse on both hands, not just the one you overuse — it's natural to assume it's "just age" or too much time at a keyboard. But rheumatoid arthritis is something quite different from ordinary wear-and-tear, and the difference matters enormously for how it's treated. Far from home, between health systems, with aching hands you can't quite explain, it's easy to wait and hope it passes. This guide explains what rheumatoid arthritis actually is, how it's diagnosed and treated, and — honestly — where cell-based research does and does not fit. If you want the wider picture first, start with our guide to what an autoimmune disease is.

What is rheumatoid arthritis?

Rheumatoid arthritis (RA) is a chronic autoimmune disease. In an autoimmune disease the immune system, which is built to tell you apart from a genuine threat, loses that self-tolerance and turns on the body's own tissue ⁴. In RA specifically, the immune system attacks the synovium — the thin lining of the joints — causing inflammation that swells the joint, and over time can erode the cartilage and bone within it ¹.

This is the crucial distinction from osteoarthritis, the far more common "wear-and-tear" arthritis. Osteoarthritis is mechanical: cartilage gradually wears down with age and use. Rheumatoid arthritis is immune-driven and systemic — it is a whole-body inflammatory disease that happens to show up loudest in the joints ¹. Two people can have "arthritis" and have almost opposite problems, which is why getting the right label early changes everything.

Who gets rheumatoid arthritis?

RA is common enough that most people know someone with it: it affects roughly 0.5–1% of adults ³⁴. It is strongly skewed by sex — women are two to three times more likely to develop it than men, with an estimated lifetime risk of about 3.6% for women versus 1.7% for men ³⁴. It can begin at any age but most often appears in middle age. Smoking and a family history both raise the risk, which is part of why doctors ask about them.

What does it feel like? Common symptoms

The hallmark of RA is a particular pattern rather than any single symptom. It typically begins in the small joints of the hands, wrists and feet, and it tends to be symmetric — affecting the same joints on both sides of the body at once ⁴. The most recognisable features include:

• Morning stiffness — joints that are stiff for more than 30 minutes to an hour after waking, easing as the day goes on ¹.
• Symmetric joint swelling and pain — warm, tender, swollen knuckles and wrists on both hands rather than one ⁴.
• Fatigue, low fevers and a general unwell feeling — because RA is systemic, many people feel run down, not just sore ².

Because it is a whole-body disease, RA can also reach beyond the joints. It can affect the lungs, heart, eyes and blood vessels, and it raises the long-term risk of cardiovascular disease — one reason it is taken seriously and monitored even when the joints feel manageable ⁴.

How is rheumatoid arthritis diagnosed?

There is no single test that says "yes, RA." Diagnosis combines the pattern of symptoms, a physical examination, blood tests and sometimes imaging ². Two antibody blood tests carry particular weight:

• Rheumatoid factor (RF) — often raised in RA, but it can also be positive in healthy people and in other conditions, so it is suggestive rather than conclusive ⁴.
• Anti-CCP antibodies (anti-cyclic citrullinated peptide) — more specific to rheumatoid arthritis than RF, so a positive result is a stronger pointer toward the diagnosis ⁴.

Doctors read these alongside inflammation markers (ESR and CRP) and, where useful, X-rays or ultrasound of the joints. As with any lab work, reference ranges differ slightly between laboratories, so results are interpreted by the doctor who ordered them — not against a fixed number online.

Why early treatment matters: the "window of opportunity"

This is the single most important idea in modern RA care. There is a window of opportunity — generally the first months after symptoms begin — in which starting effective treatment can prevent the joint damage that, once it happens, is irreversible ³¹. Joints that are protected early can stay functional for decades; joints left to inflame unchecked can erode permanently. This is why "wait and see" is the wrong instinct with RA, and why a swollen, symmetric, persistently stiff set of joints is worth getting assessed promptly rather than enduring.

How is rheumatoid arthritis treated?

RA cannot yet be cured, but for most people it is now a well-controlled long-term condition, and treatment has improved dramatically. The strategy is called treat-to-target: aim for remission or low disease activity, measure progress, and adjust ⁴⁵. The proven mainstays are:

• DMARDs (disease-modifying anti-rheumatic drugs) — the foundation of care. Unlike painkillers, these slow the disease itself. Methotrexate is the first-line choice for most people ⁴⁵.
• Biologics — targeted drugs such as TNF inhibitors that block specific parts of the immune response, added when DMARDs alone don't reach the target ⁴⁵.
• Short-term anti-inflammatories and steroids — NSAIDs and brief courses of corticosteroids to control symptoms and flares while the disease-modifying drugs take effect ¹.

Alongside medication, staying active, not smoking, and steady follow-up with a rheumatologist all matter ¹². The aim is to keep the disease quiet and the joints working — which is very achievable when treatment starts early and is adjusted properly.

Where does regenerative medicine fit?

Because RA is fundamentally a disorder of a dysregulated immune system, the idea of re-regulating that system is an active research interest — and it is also where honesty matters most. Mesenchymal stem cells (MSCs) are being studied for RA because of their immune-modulating signalling, the same property explored in other autoimmune conditions such as lupus and psoriasis.

The honest status is this: MSC-based therapy for rheumatoid arthritis is investigational and early-phase only. The evidence comes from small, early trials; there are no large randomised controlled trials establishing efficacy, and it is not an established or approved treatment ⁵. Tellingly, the same scientific review that explores MSCs for RA is explicit that DMARDs remain the mainstay of treatment ⁵. Cell-based therapy here is a research frontier, not a shortcut around proven care — and certainly not a reason to delay seeing a rheumatologist during the window when proven drugs can prevent permanent damage.

What we see at the clinic

In our consultations in Pattaya, the people asking about regenerative options for RA are often those who have lived with stiff, painful joints for a while — sometimes undiagnosed, sometimes managed on and off between countries. We take that seriously, and we are straight with them. We do not replace rheumatology care, and we do not present stem-cell therapy as a cure or as an alternative to the proven DMARDs and biologics that protect joints. Where someone is curious about the science, we explain exactly where the evidence stands — that MSC work in RA is early and investigational — and why prompt specialist diagnosis and treatment, especially within the early window, is non-negotiable. Often the most useful thing we do is encourage someone to get properly assessed rather than wait.

Common questions

How is rheumatoid arthritis different from osteoarthritis? Osteoarthritis is mechanical wear-and-tear of cartilage, usually in the joints you've used most; rheumatoid arthritis is an autoimmune disease in which the immune system attacks the joint lining, typically in a symmetric pattern across the small joints, and it can affect the whole body ¹. The treatments are completely different, which is why the distinction matters.

Is rheumatoid arthritis curable? No — there is currently no cure. But it is very treatable: with early, proven treatment most people reach remission or low disease activity and keep their joints working well ⁴⁵.

What do the RF and anti-CCP blood tests mean? Both are antibodies that support an RA diagnosis. Rheumatoid factor can be positive in other situations too, while anti-CCP is more specific to rheumatoid arthritis, so it carries more weight ⁴. Neither is read in isolation — your doctor combines them with your symptoms and exam, and lab ranges vary slightly between labs.

Can RA affect more than my joints? Yes. Because it is systemic, RA can involve the lungs, heart, eyes and blood vessels, and it raises cardiovascular risk over time — which is why it's monitored beyond just the joints ⁴.

Is stem-cell therapy a proven treatment for RA? No. MSC therapy for rheumatoid arthritis is investigational and confined to small, early trials, with no large studies establishing that it works — it is not approved or established care, and proven DMARDs and biologics come first ⁵. If you're weighing your options, our guide on whether regenerative medicine is right for you lays out the honest questions to ask.

Key takeaway

Rheumatoid arthritis is not wear-and-tear — it is the immune system attacking the joint lining, usually in a symmetric pattern across the small joints, and it can reach the rest of the body too. The single most important fact is the window of opportunity: starting proven treatment early — DMARDs led by methotrexate, with biologics added as needed — can prevent joint damage that later becomes irreversible ³⁴. Cell-based therapy is a genuine research frontier, but it remains early and investigational ⁵ — not a substitute for seeing a rheumatologist and using the treatments we know work.